Evolving developments in the regulations applied to the pharmaceutical industry, public opinion on standards of ethical behaviour and the global economic situation make this a challenging time to be a compliance professional or legal counsel responsible for ensuring adherence to applicable laws, regulations and codes of practice within our industry.

The PCF International Pharma Congress brings together senior global compliance professionals and legal counsel from around the world to share experiences and best practices to clarify these changes and potential responses to them. In Europe, regulators are increasingly active at both national and European levels. In the USA, the newly revised PhRMA codes and the new Obama administration are beginning to have a significant impact across the pharmaceutical industry. In Asia, governments are bringing in new legislation and/or enforcing existing legislation to dispel perceptions of corruption and/or conflicts of interest within the public sector.

Keynote speakers representing the IFPMA, EFPIA, and patients will give their views on the changes affecting our industry and how pharmaceutical companies can make a real difference during these challenging times. Panel discussions will focus on transparency and international compliance. There also will be smaller track discussions on the new European Pharma Package, clinical trials in emerging markets and a selection of case study sessions. Pharmaceutical compliance leaders will share their views in a valuable open forum.

If you want to find out how to manage compliance in these challenging times, the PCF International Pharma Congress will give you the information that you need.